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Impact of Early Coronary Artery Bypass Graft in an
Unselected Acute Coronary Syndrome Patient Population
Pedro Monteiro, MD; on behalf of the Portuguese Registry on Acute Coronary Syndromes
Background—Performance of coronary artery bypass graft (CABG) during an acute coronary syndrome (ACS) is mainly
used in high-risk patients. Although potentially life-saving, patients undergoing early CABG are traditionally associated
with a worse outcome than those not requiring CABG. Is this really true in an unselected ACS population? The aim of
this study was to evaluate, in an ACS population, if the performance of CABG during the index hospitalization
influences in-hospital outcome.
Methods and Results—Retrospective analysis of a nationwide database of 12 988 ACS patients admitted since 2002. Of
those, 267 patients underwent CABG during the index hospitalization (group A) and 12 721 did not (group B). Group
B patients were further divided in 2 subgroups: those submitted to percutaneous coronary interventions (PCI) (group B1;
n3948) during the index hospitalization and those not submitted to mechanical revascularization (group B2; n8773).
Patients from group A more frequently had diabetes, hypercholesterolemia, hypertension, and previous angina; they
were also more often on cardiovascular medication before admission. Patients that underwent CABG were more often
in Killip class IV at admission (4.8% versus 1.4% versus 2.0%); they also received more nitrates and catecholamines.
Left ventricular function was better in group B1. Group A patients were more often on mechanical ventilation and
intra-aortic pump and they had more in-hospital complications (31.1% versus 18.7% versus 17.3%), namely recurrent
angina, re-infarction, and mechanical complications. They had a more severe coronary anatomy and the culprit lesion
was more frequently on the left main (7.7% versus 0.5% versus 2.2%). However, their in-hospital mortality was
significantly lower (1.1% versus 2.2% versus 6.8%; P0.001). Multivariate analysis showed that performance of early
CABG was an independent predictor of lower mortality (odds ratio of 0.12), as were the use of low-molecular-weight
heparins, beta-blockers, and angiotensin-converting enzyme inhibitors.
Conclusions—In unselected patients admitted for ACS, performance of early CABG, despite being performed in
higher-risk patients, is associated with very low in-hospital mortality, even when compared with the mortality of
lower-risk population not submitted to early CABG. Therefore, early performance of this procedure should be
considered more often in eligible patients. (Circulation. 2006;114[suppl I]:I-467–I-472.)
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Acute coronary syndromes (ACS) are important causes ofdeath and morbidity among coronary artery disease
patients. In recent years, treatment of ACS patients was
significantly improved, leading to the decrease of in-hospital
and long-term mortality.1–4 In many patients with ACS in
whom coronary artery bypass graft (CABG) is indicated, the
decision is to postpone it for a few days, so that the ACS can
be “cooled” and the surgery performed with lower risk for the
patient. This common practice leads to the fact that CABG in
the first few days after an ACS is mainly used to treat
life-threatening situations, like mechanical complications or
severe left main coronary artery disease.5 However, a ques-
tion remains largely unanswered: what is the impact of early
CABG in the in-hospital outcome in an unselected “real
world” ACS population?
Methods and Results
The Portuguese Registry on ACS is a prospective and
observational registry, started in 2002. All the Portuguese
cardiology departments were invited to participate; 44 ac-
cepted (see appendix A).
Four centers were teaching hospitals, 12 were specialty
hospitals, and 28 were community hospitals; 16 were consid-
ered large and 28 were small hospitals. All of them were in
urban areas, with 31 in high-density and 13 in low-density
areas; 22 centers had on-site cath labs and 8 had on-site
cardiac surgery departments.
Inclusion Criteria
All ACS patients were admitted between January 2002 and
December 2004 and their records were available in the
Portuguese ACS registry database.
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Statistical Analysis
Continuous variables are presented as mean and interquartile
intervals (percentiles 25 and 75) and were evaluated with
analysis of variance test or Student t test. Categorical vari-
ables were compared using 2 test.
Statement of Responsibility
The authors had full access to the data and take full
responsibility for their integrity. All authors have read and
agree to the manuscript as written.
Definition of Study Groups
A total of 12 988 registries were received. Patients were
divided in 2 groups, according to the performance (group A;
n267) or not (group B; n 12 721) of CABG during the
index hospital admission for ACS. Group B patients were
then divided in 2 subgroups: those submitted to percutaneous
coronary interventions (PCI) (group B1; n3948) during the
index hospitalization and those not submitted to mechanical
revascularization (Group B2; n8773).
Diagnosis and Baseline Population Characteristics
Table 1 shows the 3 groups’ general characteristics regarding
demographic data, risk factors, and previous cardiovascular
medication.
Male gender was more prevalent in group B1, whereas B2
patients were older. No significant differences were found
regarding body mass index (BMI).
Diabetes, hypercholesterolemia, hypertension, and previ-
ous angina were more prevalent in group A, resulting in
higher use of previous cardiovascular medication in this
group (see Table 1).
Regarding angina characteristics, in group A 75.7% had
chest pain for 20 minutes, 53.6% had chest pain at hospital
admission, and 47.9% had 1 angina episode in the last 24
hours; in groups B1 and B2, there were more cases of
prolonged chest pain (84.5% and 79.3%%; P0.05) and less
prehospital angina recurrence (34.6% and 27.8%; P0.05),
whereas angina at admission was higher in B1 patients
(61.3%; P0.05). Killip class IV on admission was more
frequent in group A patients (4.8% versus 1.4% versus 2.0%;









Aspirin (%) 97.3 98.9 96.3 0.05
Clopidogrel (%) 35.9 87.7 26.1 0.05
LMWH (%) 84.7 78.4 89.6 0.05
GP IIb/IIIa inhib (%) 26.0 53.1 16.2 0.05
Nitrates (%) 95.5 86.2 86.8 0.05
Beta-blockers (%) 75.9 79.9 77.2 0.05
ACE inhibitors (%) 75.9 72.9 69.4 0.05
CCBs (%) 17.2 10.8 17.5 0.05
Statins (%) 86.2 89.5 75.8 0.05
Chatecolamines
(%)
19.2 5.1 7.4 0.05
ACE indicates angiotensin-converting enzyme; CCBs, calcium channel blockers; LMWH, low-molecular weight
heparins; GP IIb/IIIa Inib, glycoprotein IIb/IIIa inhibitors.
TABLE 1. Comparison of Demographic Data, Main Coronary Artery Disease Risk Factors, and









Male (%) 72.8 75.5 66.5 0.05
Mean age (years) 67 (59–74) 63 (53–72) 70 (59–78) 0.05
Mean BMI (kg/m2) 27 (24–29) 27 (24–29) 27 (24–29) n.s.
Diabetes (%) 32.2 22.7 28.0 0.05
Hypertension (%) 63.3 56.4 61.1 0.05
Hypercholesterolemia (%) 51.3 47.3 41.0 0.05
Smoking habits (%) 22.8 35.3 20.3 0.05
Aspirin (%) 32.6 20.2 24.4 0.05
Beta-blockers (%) 22.5 15.1 15.4 0.05
ACE inhibitors (%) 27.7 18.6 24.6 n.s.
Statins (%) 24.0 16.9 18.4 0.05
ACE indicates angiotensin-converting enzyme, BMI, body mass index.
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P0.05), whereas Killip class I was less frequent (73.9%
versus 89.0% versus 75.5%; P0.05).
Both cardiac troponins (69.3% versus 83% versus 81.6%;
P0.05) and creatin kinase–MB fraction (CK-MB) (55.8%
versus 71.4% versus 68.8%; P0.05) were less frequently
elevated in group A.
Pharmacological Therapy During Hospital Stay
Group A received more nitrates, angiotensin-converting en-
zyme inhibitors, and catecholamines, whereas group B1 re-
ceived more clopidogrel, aspirin, glycoprotein IIb/IIIa inhib-
itors, beta-blockers, and statins, and group B2 received more
low-molecular-weight heparins and calcium channel blockers
(Table 2).
Left Ventricular Function Evaluation and
Maximal Killip Class
Echocardiography was the method most often used to eval-
uate left ventricular function, which was better in patients
treated with early PCI (Table 3).
Group A patients reached more often a Killip class IV
during hospital stay (12.9% versus 5.0% versus 6.6%;
P0.05).
Use of Invasive Procedures During Hospital Stay
Group A required mechanical ventilation, intra-aortic balloon
pump, and provisional or permanent pacemakers more often
(Table 4).
Use of Coronary Angiography, Surgical, and
Nonsurgical Revascularization Procedures
Besides all group A and B1 patients, 32.8% of group B2
patients were also submitted to coronary angiography during
hospital stay. Coronary anatomy was more severely diseased
in group A, with more significant stenosis in the left main
(36.3% versus 1.5% versus 2.8%; P0.05), left anterior
descending (84.6% versus 65.7% versus 21.3%; P0.05), left
circumflex (68.5% versus 43.8% versus 17.4%; P0.05), and
right coronary (67.0% versus 52.0% versus 17.7%; P0.05)
arteries. Group A also had higher incidence of 2- and 3-vessel
disease.
Elective coronary angiography for risk stratification was
the main reason to perform the examination in all groups;
urgent coronary angiography was more frequent in group A,
whereas coronary angiography in context of an acute STEMI
was more frequent in B1, and after a positive stress test in B2
(Table 5). Primary or non-primary PCI was performed in
7.9% of group A patients. Time interval between ACS and
main intervention (CABG or PCI) was 9.111.3 days after
admission in group A and 3.74.9 days in B1 (P0.05).
Complications
Recurrent angina (the most frequent in-hospital complica-
tion), re-infarction, major hemorrhage (including intracranial
bleeding), and mechanical and overall complications were
more frequent in group A.
However, patients submitted to early CABG had an in-
hospital mortality significantly lower than those submitted to
early PCI or not submitted to early mechanical revascular-
ization (1.1% versus 2.2% versus 6.8%; P0.05) (Table 6).
Pharmacological Therapy at Discharge
Group A patients received more nitrates, but less aspirin and
beta-blockers, whereas group B1 received more clopidogrel
and statins and group B2 received more calcium channel
blockers (Table 7).
Multivariate and Subgroup Analysis
Multivariate analysis showed that performance of early
CABG (but not early PCI) was an independent predictor of
lower mortality (odds ratio, 0.12), as were low-molecular-
weight heparins, beta-blockers, and angiotensin-converting
enzyme inhibitors (Table 8).
Heterogeneity of the population not submitted to early
mechanical revascularization (group B2) led to a comparison
between patients that did (n5813) and did not (n7175)
undergo coronary angiography during their index ACS hos-
pitalization. Patients not submitted to coronary angiography









Normal LV function (%) 53.9 64.0 53.2 0.05
Mild to moderate dysfunction (%) 35.5 31.0 33.7 0.05
Severe LV dysfunction (%) 10.6 5.0 13.1 0.05









Swan-Ganz catheter (%) 0.4 0.3 0.1 NS
Mechanical ventilation (%) 16.5 2.3 2.2 0.05
IABP (%) 11.2 1.3 0.2 0.05
Pacemaker (%) 3.0 2.6 1.9 0.05
IABP indicates intra-aortic balloon pump.
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were less often male and had more previous diabetes, myo-
cardial infarction, and cardiovascular medication. During
hospitalization, they received fewer drugs recommended by
guidelines, and their left ventricular function was worse (data
not shown). They showed a trend toward lower in-hospital
complications rate (67.5% versus 69.4%; Pnot significant),
but their in-hospital mortality was significantly higher (9.1%
versus 2.1%). Multivariate analysis showed that performance
of coronary angiography was an independent predictor of low
in-hospital mortality (odds ratio, 0.27).
Another subgroup analysis was performed, considering 3
patient groups, within the population submitted to early
coronary angiography (early CABG, early PCI, and nonre-
vascularized): CABG patients had the lowest in-hospital
mortality (1.1%), followed by nonrevascularized patients
(1.9%) and those submitted to PCI (2.2%; Pnot significant,
except CABG versus PCI). Multivariate analysis showed that,
even in this subpopulation of patients submitted to coronary
angiography, early CABG (unlike early PCI) was an inde-
pendent predictor of good in-hospital prognosis (odds ratio,
0.27).
Discussion
During past decade, a “revolution” in ACS diagnosis and
treatment has occurred. Cardiac troponins made the diagnosis
more accurate, leading to a redefinition of acute myocardial
infarction.6 Coronary angiography and PCI became more
widely available and more often used with better results,
partially because of recent therapeutic advances like drug-
eluting stents, clopidogrel, and glycoprotein IIb/IIIa inhibi-
tors.1–4 Results of several clinical trials led to a shift from
more conservative approaches to being more invasive early in
the ACS natural history.7
All these advances led to a progressive decrease in the use
of CABG early in the history of ACS patients,8 being used
primarily in certain ACS complications and in patients with
severe left main disease.
However, a question remained largely unanswered: what is
the impact of early CABG in an unselected ACS population?
Some authors have studied the impact of the type of urgent
CABG performed in the outcome of these patients. Ochi et al
reported that off-pump surgery is feasible and safe in this set
of patients,9 partially contradicting previously reports stating
that this surgical technique, although feasible, was associated
to significant morbidity and mortality.10
The CRUSADE investigators11 clearly showed than an
early invasive strategy (involving early angiography, usually
followed by PCI or CABG) is the best in ACS, even in an
unselected population. This result is in line with a recently
published substudy of the GUSTO IV-ACS trial, which also
compared ACS patients submitted or not to early revascular-
ization (PCI or CABG).12
However, our study goes beyond these results, because it
shows that the performance of early CABG can be associated
to improved in-hospital mortality, even when the comparator
is a group of patients where 54.3% underwent coronary
angiography and 31.7% received early PCI. Regarding mor-
bidity, the situation is opposite: patients who underwent
urgent CABG had higher morbidity. However, this may
reflect the fact that this is an high-risk population, in which
the rate of nonfatal events is usually higher; however, most of
this events occurred before surgery and may have weighed on









Patients studied (%) 100 100 32.8% —
Primary coronary angiography (%) 11.8 29.1 5.0 0.05
Rescue coronary angiography (%) 1.8 3.6 0.7 NS
Urgent coronary angiography (%) 38.6 23.1 23.1 0.05
Elective coronary angiography (%) 43.2 37.2 56.1 NS
Post-stress test coronary angiography (%) 4.5 6.9 15.2 0.05









Recurrent angina (%) 17.6 9.0 5.9 0.05
Re-infarction (%) 3.4 2.7 1.3 0.05
Major bleeding (%) 9.4 1.4 1.2 0.05
Mechanical complication (%) 4.9 0.9 1.4 0.05
Second/third AV block (%) 3.0 3.2 3.3 NS
VF(%) 2.2 3.0 1.9 0.05
Death(%) 1.1 2.2 6.8 0.05
Total (%) 31.1 18.7 17.3 0.05
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the decision to undergo early CABG (that is, this high
morbidity was often the cause of early CABG and not caused
by early CABG).
Recently published results of a EuroHeart Survey on Acute
Coronary Syndromes substudy13 also shows a trend toward
lower in-hospital mortality in the subset of patients treated
with CABG, leading the authors to conclude that “CABG
remains an effective and safe means to achieve revascular-
ization among ACS patients in current clinical practice”.
However, a recent study by Thielmann et al shows that,
even within ACS patients undergoing urgent CABG, it is
possible to stratify them regarding mortality, using simple
markers, like preoperative troponin I.14
In our study, gender did not independently influence the
decision to undergo urgent CABG, unlike the reports in a
substudy of the CURE trial.15 Unlike results of the GRACE
investigators,16 and although in our study patients submitted
to early CABG had an higher morbidity rate, CABG did not
increased the nonhemorrhagic stoke rate.
Although the 6-month follow-up data in our registry are
currently available only for 30% of the patient population
(3515 patients), mortality remains lower in the group submit-
ted to CABG (2.6% versus 3.1% versus 8.6%; P0.05).
These preliminary results of the CABG “arm” of our registry
are in line with those reported by the SoS investigators
regarding a 1-year composite endpoint of death or myocardial
infarction in a ACS population.17
The 2 subgroup analyses performed reinforce the results
from the main study and strengthen the idea that, in eligible
ACS patients, early CABG should be performed to improve
their in-hospital outcome.
Limitations
Although all the participating centers were asked to include in
the registry all their ACS patients, it was not possible to
confirm if that was achieved. Because of its characteristics, it
is not possible to determine the number and clinical features
of patients who were admitted during the timeframe analyzed,
but whose ACS was not diagnosed. Data from the prespeci-
fied 6-month follow-up is not available for all ACS patients,
so a full and definitive analysis of those data at the moment
is not possible.
Conclusions
This large dataset from a nationwide prospective registry,
including both small peripheral hospitals and large reference
and university hospitals, represents a “real world” cardiology
practice regarding ACS patients.
In this patient population, performance of CABG during
the index hospitalization for ACS seems to represent a
short-term mortality benefit. This is particularly relevant,
because this group of patients had a worse risk factor profile,
more coronary lesions, higher maximal Killip class, and
increased in-hospital morbidity.
Therefore, we conclude that early CABG should be con-
sidered more often in eligible ACS patients.
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